Scarica l'app Stockscreener
3.91
10.45%
0.37
Precedente Chiudi:
$3.54
Aprire:
$3.5
Volume 24 ore:
36,752
Relative Volume:
1.16
Capitalizzazione di mercato:
$32.78M
Reddito:
$7.50M
Utile/perdita netta:
$-7.79M
Rapporto P/E:
-3.1734
EPS:
-1.2321
Flusso di cassa netto:
$-24.56M
1 W Prestazione:
-4.63%
1M Prestazione:
-14.44%
6M Prestazione:
-26.92%
1 anno Prestazione:
+40.65%
Intervallo 1D:
$3.50
$3.93
Intervallo di 1 settimana:
$3.50
$4.14
Portata 52W:
$2.07
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
3.93 | 29.52M | 7.50M | -7.79M | -24.56M | -1.2321 |
VRTX
Vertex Pharmaceuticals Inc
|
442.81 | 108.72B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
627.11 | 64.89B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
845.36 | 50.57B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.98 | 39.06B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.99 | 33.16B | 742.00K | -1.37B | -1.07B | -7.0731 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Maxim Group | Buy |
| 2024-04-02 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Iniziato | H.C. Wainwright | Buy |
Evaxion A S Adr Borsa (EVAX) Ultime notizie
European ADRs Edged Higher In US Trading - Finimize
Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints - TipRanks
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer - GlobeNewswire Inc.
Endesa S.A. – Unsponsored ADR (OTCMKTS:ELEZY) Given Average Rating of “Strong Sell” by Brokerages - Defense World
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
European ADRs Rose, While Biotech Names Did The Heavy Lifting - Finimize
Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks
Evaxion A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright - Defense World
Evaxion A/S (NASDAQ:EVAX) Price Target Cut to $9.00 by Analysts at Lake Street Capital - Defense World
Evaxion Earnings Report: Q4 Overview - Sahm
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Short Interest Up 20.9% in February - Defense World
Evaxion Biotech's Earnings: A Preview - Sahm
European ADRs Slip Slightly As Winners And Losers Split - Finimize
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Target Price at $12.33 - Defense World
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out - Sahm
European Firms Make Gains On US Markets As ADR Index Rises - Finimize
European ADRs Edge Up With Gains Led By Evaxion - Finimize
Evaxion Biotech’s Earnings Call Highlights Strategic Growth - TipRanks
Evaxion Biotech Reports Strong Q3 2025 Results - TipRanks
Take off with Evaxion A/S ADR (EVAX): Get ready for trading - setenews.com
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade
Evaxion Biotech Reports Q2 2025 Financial Results - TipRanks
Evaxion A S Adr Azioni (EVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):